MEDIPOST Valuation

078160 Stock  KRW 12,350  380.00  3.17%   
At this time, the firm appears to be overvalued. MEDIPOST secures a last-minute Real Value of W9527.7 per share. The latest price of the firm is W12350.0. Our model forecasts the value of MEDIPOST from examining the firm fundamentals such as return on equity of 1.87, and Profit Margin of (0.10) % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
12,350
Please note that MEDIPOST's price fluctuation is very steady at this time. Calculation of the real value of MEDIPOST is based on 3 months time horizon. Increasing MEDIPOST's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since MEDIPOST is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MEDIPOST Stock. However, MEDIPOST's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  12350.0 Real  9527.7 Hype  12350.0 Naive  13114.47
The real value of MEDIPOST Stock, also known as its intrinsic value, is the underlying worth of MEDIPOST Company, which is reflected in its stock price. It is based on MEDIPOST's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MEDIPOST's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
9,528
Real Value
13,585
Upside
Estimating the potential upside or downside of MEDIPOST Co helps investors to forecast how MEDIPOST stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MEDIPOST more accurately as focusing exclusively on MEDIPOST's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6,71110,78714,863
Details
Hype
Prediction
LowEstimatedHigh
12,34412,35012,356
Details
Naive
Forecast
LowNext ValueHigh
13,10813,11413,121
Details

MEDIPOST Total Value Analysis

MEDIPOST Co is presently forecasted to have takeover price of 453 B with market capitalization of 241.31 B, debt of 1.23 B, and cash on hands of 9.72 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MEDIPOST fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
453 B
241.31 B
1.23 B
9.72 B

MEDIPOST Investor Information

The company has Price/Earnings (P/E) ratio of 9635.53. MEDIPOST had not issued any dividends in recent years. The entity had 2:1 split on the 29th of March 2019. Based on the key indicators related to MEDIPOST's liquidity, profitability, solvency, and operating efficiency, MEDIPOST Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

MEDIPOST Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MEDIPOST has an asset utilization ratio of 21.59 percent. This suggests that the Company is making W0.22 for each dollar of assets. An increasing asset utilization means that MEDIPOST Co is more efficient with each dollar of assets it utilizes for everyday operations.

MEDIPOST Ownership Allocation

MEDIPOST maintains a total of 15.38 Million outstanding shares. MEDIPOST Co secures 6.96 % of its outstanding shares held by insiders and 6.55 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

MEDIPOST Profitability Analysis

The company reported the revenue of 54.86 B. Net Loss for the year was (966.42 M) with profit before overhead, payroll, taxes, and interest of 30.89 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MEDIPOST's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MEDIPOST and how it compares across the competition.

About MEDIPOST Valuation

The stock valuation mechanism determines MEDIPOST's current worth on a weekly basis. Our valuation model uses a comparative analysis of MEDIPOST. We calculate exposure to MEDIPOST's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MEDIPOST's related companies.
MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. MEDIPOST Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea. MEDIPOST is traded on Korean Securities Dealers Automated Quotations in South Korea.

8 Steps to conduct MEDIPOST's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates MEDIPOST's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MEDIPOST's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain MEDIPOST's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine MEDIPOST's revenue streams: Identify MEDIPOST's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research MEDIPOST's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish MEDIPOST's growth potential: Evaluate MEDIPOST's management, business model, and growth potential.
  • Determine MEDIPOST's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MEDIPOST's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for MEDIPOST Stock analysis

When running MEDIPOST's price analysis, check to measure MEDIPOST's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIPOST is operating at the current time. Most of MEDIPOST's value examination focuses on studying past and present price action to predict the probability of MEDIPOST's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIPOST's price. Additionally, you may evaluate how the addition of MEDIPOST to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins